FDA, Danco Urge High Court To Reverse 5th Circuit’s Abortion Drug Decision
WASHINGTON, D.C. — The U.S. Food and Drug Administration and Danco Laboratories LLC, the manufacturer of Mifeprex-brand mifepristone, on Jan. 23 filed separate opening briefs in the U.S. Supreme Court, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article